Clinical Trials Sponsored by Towa Pharmaceutical Co.,Ltd.

Total 3756 results

Boryung Pharmaceutical Co., Ltd

Completed

A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia (FIMASTAR)

Hypertension and Dyslipidemia

Korea, Republic of
Dongkook Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds

Nasolabial Folds

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin (ENHANCE-MEXT)

T2DM (Type 2 Diabetes Mellitus)

Korea, Republic of
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study of TS-143 in Healthy Adult Male Subjects (Multiple-Dose Administration)

Healthy Participants

Japan
Taisho Pharmaceutical Co., Ltd.

Completed

Clinical Study on Histamine H3 Receptor Occupancy of TS-091 by PET Examination in Healthy Adult Subjects

Healthy Subjects

Japan
Boryung Pharmaceutical Co., Ltd

Completed

Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor (DETECT)

Breast Cancer | Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | NSCLC | Prostate Cancer

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of Brexpiprazole in Patients With Major Depressive Disorder

Major Depressive Disorder

Japan
Daewoong Pharmaceutical Co. LTD.

Completed

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

Healthy

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Terminated

Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo

Mild to Moderate COVID-19

Korea, Republic of
SATO Pharmaceutical Co., Ltd.

Active, not recruiting

Safety and Tolerability Study of SKX-16 in Subjects With Moderate to Severe Distal Subungual Onychomycosis

Onychomycosis of Toenail

United States
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients

Type 2 Diabetes

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Investigate the Systemic Exposure, Safety, and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Male Volunteers

Healthy

Korea, Republic of
Samjin Pharmaceutical Co., Ltd.

Completed

Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B

Chronic Hepatitis b

Korea, Republic of
Biotech Pharmaceutical Co., Ltd.

Completed

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

Esophageal

China
Qilu Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

Multiple Myeloma | Recurrent or Refractory

China
Daewon Pharmaceutical Co., Ltd.

Completed

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

Osteoarthritis | Rheumatoid Arthritis | Back Pain | Acute Upper Respiratory Tract Infection

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.

Covid19

Korea, Republic of
Qilu Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment

Infertility

China
Daewoong Pharmaceutical Co. LTD.

Completed

Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects

Phase 1 Study, Healthy Volunteers

Korea, Republic of
Nihon Pharmaceutical Co., Ltd

Completed

Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy

Bowel Disease

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer

Head and Neck Cancer

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Pharmacodynamic Study of Cilostazol in Healthy Volunteers (CiloMecT)

Healthy

Germany
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)

Healthy

China
Qilu Pharmaceutical Co., Ltd.

Completed

Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD)

Healthy

China
Otsuka Pharmaceutical Co., Ltd.

Completed

Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism

Autism

Japan
Boryung Pharmaceutical Co., Ltd

Completed

A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Smoking Cessation

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Combination (FINAL)

Essential Hypertension

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic Migraine

Migraine

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Clinical Pharmacology Trial to Investigate the Dose of OPC-61815 Injection Equivalent to Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure

Congestive Heart Failure

Japan
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers

Prostate Cancer

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

Smoking Cessation

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Safety Study of OPC-12759 Ophthalmic Solution

Dry Eye Syndromes

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects

Healthy Adult Male

Japan
Jeil Pharmaceutical Co., Ltd.

Completed

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

Overactive Bladder(OAB)

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome

Sjogren's Syndrome | Xerostomia

Japan
Yooyoung Pharmaceutical Co., Ltd.

Completed

Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

Non-erosive Reflux Disease

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Completed

Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds

Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Bioequivalence Between Single Administration of ASC-01 (Aripiprazole/Sertraline Combination Drug) and Concomitant Single Administration of Aripiprazole and Sertraline, and Food Effect on Pharmacokinetics of ASC-01 in Healthy Male Adults

Healthy Male Adults

Japan
Daewoong Pharmaceutical Co. LTD.

Unknown

Pharmacokinetics and Safety of DWJ1451 in Healthy Adults

Healthy

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)

Carcinomatous Edema

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)

Acute Myeloid Leukemia

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction. (CSPS)

Cerebral Infarction

Japan
Otsuka Pharmaceutical Co., Ltd.

Completed

A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer

Colorectal Cancer

Japan
Hyundai Pharmaceutical Co., LTD.

Completed

HDDO-1756 Bio Equivalence Study

Hyperlipidemias

Korea, Republic of
Otsuka Pharmaceutical Co., Ltd.

Completed

Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome

Atopic Dermatitis

Japan
ASKA Pharmaceutical Co., Ltd.

Completed

Clinical Study to Evaluate Efficacy and Safety of TAK-385 40 mg Compared With Leuprorelin in Patients With Endometriosis

Endometriosis

Japan
Qilu Pharmaceutical Co., Ltd.

Unknown

A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects

Healthy

Germany, United Kingdom
Qilu Pharmaceutical Co., Ltd.

Unknown

Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients

Non-small Cell Lung Cancer

China
Taiho Pharmaceutical Co., Ltd.

Completed

Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia (TERRA)

Colorectal Cancer

Korea, Republic of, China, Thailand
Otsuka Pharmaceutical Co., Ltd.

Completed

A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH

Syndrome of Inappropriate Antidiuretic Hormone Secretion

Japan

3

Subscribe